Wyss Institute at Harvard University

Learn about Jéssica Freire Feitor, PhD's journey to becoming a Postdoctoral Fellow at the Wyss, from a year and a half in the United States studying food chemistry to working in industry before pursuing a Ph.D.

In this episode of Conquer Aging or Die Trying, host Michael Lustgarten speaks to Wyss Postdoctoral Fellow Li Li about GeneSkin, the technology she’s developing for skin rejuvenation. #HealthyAging https://lnkd.in/gaxW7Rhp

Growing up in Ghana, Kwasi Adu-Berchie contracted malaria almost every year. He remembers lying in bed, under a net that was supposed to protect him from mosquitos carrying the disease, shivering despite the warm temperatures outside, and taking bitter chloroquine. Fortunately, Kwasi fully recovered, but he knows not everyone is so lucky. After formative experiences at the African Leadership Academy, he chose to pursue science, aiming to make healthcare more accessible globally. If Kwasi could #ReimagineTheWorld, people would not die from infections that are treatable in other parts of the world. At the Wyss, he is working to make that vision a reality as part of a project funded by the Gates Foundation to remove barriers to preventative malaria treatment. Read and listen to Kwasi's story: https://lnkd.in/eTVAYCUb

Last week, the Wyss' Women's Health Catalyst hosted an inspiring and insightful event to explore the pressing challenges endometriosis patients face, the obstacles hindering progress, and the cutting-edge scientific breakthroughs needed to revolutionize care. After hearing from leading researchers including Dr. Marc R. Laufer, M.D., Dr. Emily Parent, and Dr. Michael S. Rogers, attendees engaged in a lively Q&A session moderated by Wyss Scientist Sandy Elmehrath. #EndometriosisAwarenessMonth #EndoAwarenessMonth2025 #WyssWomensHealth

Wyss scientists have invented a novel metabolic labeling technology that enables the “tagging” of the surface of T cells with immune-enhancing cytokine molecules. This could help expand adoptive T cell therapies to the treatment of solid tumors. #Immunotherapy https://lnkd.in/eUWVa6F5

Over 12,000 women die of ovarian cancer every year – imagine if we could improve survival rates by at least 50%. With Wyss' iNodes technology, that could be possible. To improve the disease's prognosis, our team is developing injectable immune organs (iNodes) that could transform treatment by boosting immune responses to enable the formation of lymphoid organs. This innovative approach may also benefit other cancers and diseases by enhancing immune system effectiveness. https://lnkd.in/e65cR8gn

"This collaboration will draw on the Wyss Institute’s track record of developing innovative drug delivery systems and its experience with biocompatible materials for tissue engineering applications. We’re excited to not only collaborate with Goldberg’s team at Stanford University, but also with all the other groups involved in this visionary project," explains Core Faculty member David Mooney. Learn more about this Advanced Research Projects Agency for Health (ARPA-H) project to develop groundbreaking eye transplant technology. https://lnkd.in/eU_vdDgC

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner have vast potential for monitoring patients' physiology and response to therapies. However, to date, they only have a limited lifetime. Now, a Wyss team has developed a new coating that holds promise to substantially increase the lifespan of implanted and wearable biosensors, bringing a plethora of diagnostic and research applications within reach. Sofia Wareham Mathiassen https://lnkd.in/ebJGX9fn

Learn about Gozde Basara's path to becoming a Biofabrication Engineer at the Wyss, from her early aspirations of becoming a car designer to realizing she wanted to find a way to help patients sooner by becoming a bridge between academia and industry.

We were thrilled to host a cohort of students from BioversityMA, a MassBio initiative, at the Wyss Institute last week. Bioversity provides students with technical and professional skill training to be ready for a variety of entry-level scientific operations jobs, propelling new talent into the field of biotech.   Over the course of the afternoon, members of our community shared reflections on their own career paths, examples of current work around the Institute, and our shared passion for transformational research and innovation. Congratulations to this latest cohort of Bioversity graduates!